Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Int J Cardiol. 2016 Nov 12;228:761–770. doi: 10.1016/j.ijcard.2016.11.245

Figure 2.

Figure 2

Propensity score-adjusted hazard ratios (HRs) for association between warfarin + antihyperlipidemic drug (vs. pravastatin) and gastrointestinal bleeding/intracranial hemorrhage within 30 days of concomitant use—overall and within three prespecified time windows